Peter C. Brandt - Net Worth and Insider Trading
Peter C. Brandt Net Worth
The estimated net worth of Peter C. Brandt is at least $94,660 dollars as of 2024-09-20. Peter C. Brandt is the Director of IN8bio Inc and owns about 287,763 shares of IN8bio Inc (INAB) stock worth over $92,401. Peter C. Brandt is also the Director of Rexahn Pharmaceuticals Inc and owns about 312 shares of Rexahn Pharmaceuticals Inc (REXN) stock worth over $2,259. Details can be seen in Peter C. Brandt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter C. Brandt has not made any transactions after 2022-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter C. Brandt
Peter C. Brandt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter C. Brandt owns 3 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , Ocuphire Pharma Inc (OCUP) , and IN8bio Inc (INAB) .
Click here to see the complete history of Peter C. Brandt’s form 4 insider trades.
Insider Ownership Summary of Peter C. Brandt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REXN | Rexahn Pharmaceuticals Inc | 2019-06-06 | director |
| OCUP | Ocuphire Pharma Inc | 2010-09-09 | director |
| INAB | IN8bio Inc | 2022-08-16 | director |
Peter C. Brandt Latest Holdings Summary
Peter C. Brandt currently owns a total of 2 stocks. Among these stocks, Peter C. Brandt owns 287,763 shares of IN8bio Inc (INAB) as of August 16, 2022, with a value of $92,401 and a weighting of 97.61%. Peter C. Brandt also owns 312 shares of Rexahn Pharmaceuticals Inc (REXN) as of September 9, 2011, with a value of $2,259 and a weighting of 2.39%.
Latest Holdings of Peter C. Brandt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INAB | IN8bio Inc | 2022-08-16 | 287,763 | 0.32 | 92,401 |
| REXN | Rexahn Pharmaceuticals Inc | 2011-09-09 | 312 | 7.24 | 2,259 |
Holding Weightings of Peter C. Brandt
Peter C. Brandt Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter C. Brandt has made a total of 1 transactions in IN8bio Inc (INAB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IN8bio Inc is the acquisition of 105,263 shares on August 16, 2022, which cost Peter C. Brandt around $200,000.
According to the SEC Form 4 filings, Peter C. Brandt has made a total of 0 transactions in Rexahn Pharmaceuticals Inc (REXN) over the past 5 years. The most-recent trade in Rexahn Pharmaceuticals Inc is the acquisition of 260 shares on September 9, 2011, which cost Peter C. Brandt around $146,250.
Insider Trading History of Peter C. Brandt
- 1
Peter C. Brandt Trading Performance
GuruFocus tracks the stock performance after each of Peter C. Brandt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter C. Brandt is -41.69%. GuruFocus also compares Peter C. Brandt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter C. Brandt within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter C. Brandt's insider trading performs compared to the benchmark.
Performance of Peter C. Brandt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.6 | | | | | |
| Relative Return to S&P 500(%) | 10.1 | | | | | |
Peter C. Brandt Ownership Network
Peter C. Brandt Owned Company Details
What does Rexahn Pharmaceuticals Inc do?
Who are the key executives at Rexahn Pharmaceuticals Inc?
Peter C. Brandt is the director of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .
Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rexahn Pharmaceuticals Inc Insider Transactions
Peter C. Brandt Mailing Address
Above is the net worth, insider trading, and ownership report for Peter C. Brandt. You might contact Peter C. Brandt via mailing address: Noven Pharmaceuticals, Inc., 11960 Sw 144th Street, Miami Fl 33186.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
